Connor, Clark & Lunn Investment Management Ltd. Selecta Biosciences Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.96 - $1.6 $114,826 - $191,377	-119,611 Reduced 81.45%	27,239 $30,000
Q3 2022 Nov 10, 2022	SELL	$1.33 - $2.6 $16,014 - $31,306	-12,041 Reduced 7.58%	146,850 $241,000
Q2 2022 Aug 05, 2022	SELL	$0.67 - $1.4 $130,562 - $272,816	-194,869 Reduced 55.09%	158,891 $208,000
Q1 2022 May 12, 2022	SELL	$1.23 - $3.31 $96,620 - $260,010	-78,553 Reduced 18.17%	353,760 $435,000
Q4 2021 Feb 10, 2022	BUY	$2.89 - $4.43 $6,534 - $10,016	2,261 Added 0.53%	432,313 $1.41 Million
Q3 2021 Nov 12, 2021	BUY	$3.36 - $4.62 $701,772 - $964,937	208,861 Added 94.43%	430,052 $1.79 Million
Q2 2021 Aug 12, 2021	BUY	$2.82 - $5.01 $398,482 - $707,943	141,306 Added 176.89%	221,191 $925,000
Q1 2021 May 13, 2021	BUY	$2.92 - $5.07 $177,162 - $307,607	60,672 Added 315.79%	79,885 $361,000
Q4 2020 Feb 16, 2021	BUY	$1.64 - $3.42 $31,509 - $65,708	19,213 New	19,213 $58,000
Q3 2020 Nov 12, 2020	SELL	$2.18 - $2.84 $288,584 - $375,953	-132,378 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.83 - $4.06 $242,251 - $537,454	132,378 New	132,378 $376,000

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account